InnoCare Pharma Limited (SHA:688428)

InnoCare Pharma Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	6,327	6,241	8,287	8,698	5,929	3,970
Trading Asset Securities	681.19	759.18	-	313.29	317.06	-
Cash & Short-Term Investments	7,008	7,000	8,287	9,011	6,246	3,970
Cash Growth	-14.56%	-15.53%	-8.04%	44.28%	57.34%	67.35%
Accounts Receivable	363.57	351	276.38	127.83	45.27	0.15
Other Receivables	0.27	0.05	31.34	61.79	62.27	78.1
Receivables	363.83	351.05	307.71	189.61	107.55	78.25
Inventory	97.07	95.58	119.09	65.32	9.92	1.88
Other Current Assets	428.46	373.56	51.38	33.56	53.87	42.46
Total Current Assets	7,897	7,820	8,765	9,300	6,417	4,092
Property, Plant & Equipment	797.07	814.27	798.5	937.27	566.08	403.13
Long-Term Investments	0.48	0.4	5.66	11.71	326.1	1.16
Goodwill	3.12	3.12	3.12	3.13	3.13	3.13
Other Intangible Assets	255.97	258.14	266.03	41.31	34.17	37.02
Long-Term Deferred Charges	-	31.94	33.3	-	-	-
Other Long-Term Assets	459.53	479.43	48.06	28.04	50.95	1.05
Total Assets	9,414	9,407	9,920	10,321	7,398	4,538
Accounts Payable	165.68	128.36	134.9	118.6	84.6	5.52
Accrued Expenses	41.17	127.52	100.06	116.03	97.5	50.21
Short-Term Debt	80.06	137.45	-	-	-	-
Current Portion of Long-Term Debt	95.49	56.35	1,256	1,197	-	-
Current Portion of Leases	-	31.61	23.23	20.11	20.34	6.83
Current Unearned Revenue	-	-	-	12	19.48	6.65
Other Current Liabilities	583.21	567.99	567.66	611.52	107.39	35.25
Total Current Liabilities	1,007	1,049	2,082	2,075	329.3	104.45
Long-Term Debt	1,344	1,322	331.88	287.76	1,238	1,150
Long-Term Leases	25.21	27.44	43.65	35.44	47.44	17.17
Long-Term Unearned Revenue	270.74	263	281.78	278.2	123.61	100
Long-Term Deferred Tax Liabilities	-	-	-	-	-	6.04
Total Liabilities	2,648	2,662	2,739	2,677	1,739	1,377
Common Stock	0.02	0.02	0.02	0.02	0.02	0.02
Additional Paid-In Capital	-	12,111	12,150	11,756	9,372	6,743
Retained Earnings	-5,502	-5,520	-5,080	-4,423	-3,536	-3,544
Treasury Stock	-9.01	-3.1	-	-	-	-
Comprehensive Income & Other	12,260	137.99	77.23	263.73	-230.85	-95.05
Total Common Equity	6,749	6,725	7,148	7,597	5,605	3,104
Minority Interest	17.14	20.63	32.86	47.23	54.36	56.49
Shareholders' Equity	6,766	6,746	7,181	7,644	5,659	3,161
Total Liabilities & Equity	9,414	9,407	9,920	10,321	7,398	4,538
Total Debt	1,545	1,575	1,655	1,540	1,306	1,174
Net Cash (Debt)	5,463	5,425	6,632	7,471	4,940	2,796
Net Cash Growth	-29.89%	-18.20%	-11.22%	51.24%	76.67%	-
Net Cash Per Share	3.22	3.20	3.89	5.05	3.62	2.89
Filing Date Shares Outstanding	1,797	1,762	1,684	1,764	1,500	1,289
Total Common Shares Outstanding	1,797	1,762	1,684	1,764	1,500	1,289
Working Capital	6,890	6,771	6,683	7,224	6,088	3,988
Book Value Per Share	3.76	3.82	4.24	4.31	3.74	2.41
Tangible Book Value	6,490	6,464	6,879	7,553	5,567	3,064
Tangible Book Value Per Share	3.61	3.67	4.08	4.28	3.71	2.38
Buildings	-	422.73	364.63	224.41	81.04	-
Machinery	-	362.86	302.01	248.13	127.57	13.91
Construction In Progress	-	138.86	166.91	197.65	230.72	296.93
Leasehold Improvements	-	-	-	35.44	6.68	1.08

Updated Nov 11, 2024. Source: S&P Global Market Intelligence. Standard template. Financial Sources.